Literature DB >> 33517010

Advancing the treatment of primary influent and effluent wastewater during wet weather flow by single versus powdered activated carbon-catalyzed ozonation for the removal of trace organic compounds.

Mirna Alameddine1, Zuo Tong How1, Mohamed Gamal El-Din2.   

Abstract

For the first time, single and PAC-catalyzed ozonation were explored for the wastewater treatment during wet weather flow in a prompt and efficient process. The effect of varying the ozone (O3) specific dose on the removal of micropollutants (MPs) was first investigated with a mixture of pharmaceuticals, herbicides and perfluorinated compounds in clean water. Most MPs showed higher affinity towards catalytic ozonation. Carbamazepine and Atrazine were found to be good surrogates for fast and slow reacting compounds, respectively. Applying single or PAC-catalyzed ozonation for 1 min only after coagulation was more efficient than applying them simultaneously. PAC-catalyzed ozonation was more efficient for the removal of organics and O3-resistant MPs. Both single and PAC-catalyzed ozonation achieved 4 log removal of E. coli, reduced the acute and genetic toxicity, and estrogenic activity of the wastewater. A detailed cost analysis revealed that applying single ozonation after coagulation costs between 0.06 and 0.32 $/m3 while applying PAC-catalyzed ozonation costs between 0.32 and 0.63 $/m3 for a flow rate between 100 and 600 MLD. Through a comprehensive performance assessment, PAC-catalyzed ozonation was deemed superior with one drawback related to the disposal of PAC.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Combined sewer overflow; Cost analysis; Performance assessment; Surrogate micropollutant; Treatment trains

Year:  2021        PMID: 33517010     DOI: 10.1016/j.scitotenv.2020.144679

Source DB:  PubMed          Journal:  Sci Total Environ        ISSN: 0048-9697            Impact factor:   7.963


  1 in total

1.  Comparison of pharmaceutical removal in two membrane bioreactors with/without powdered activated carbon addition.

Authors:  Ya-Ting Liu; Qing Xia; Wei-Wei Huang; Xue-Song Yi; Li-Li Dong; Fei Yang
Journal:  RSC Adv       Date:  2022-07-21       Impact factor: 4.036

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.